Report Detail
Global Ferric Carboxymaltose Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4749124 |
- 05 October, 2026 |
- Global |
- 100 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Ferric Carboxymaltose Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Ferric carboxymaltose injection is an iron replacement product that is used to treat iron deficiency anemia (not enough iron in the blood) in patients with non-dialysis dependent chronic kidney disease (CKD), and in patients who cannot take iron supplements or who are taking iron supplements that did not work well.
This report is a detailed and comprehensive analysis for global Ferric Carboxymaltose Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ferric Carboxymaltose Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ferric Carboxymaltose Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ferric Carboxymaltose Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ferric Carboxymaltose Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ferric Carboxymaltose Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ferric Carboxymaltose Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Daiichi Sankyo, Vifor Pharma, Hencer Pharma, Lupin, Weefsel Pharma, Apollo Pharmacy, Cipla, Bosch Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ferric Carboxymaltose Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2 ml
10 ml
20 ml
15 ml
Market segment by Application
Hospital
Clinic
Major players covered
Daiichi Sankyo
Vifor Pharma
Hencer Pharma
Lupin
Weefsel Pharma
Apollo Pharmacy
Cipla
Bosch Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ferric Carboxymaltose Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ferric Carboxymaltose Injection, with price, sales quantity, revenue, and global market share of Ferric Carboxymaltose Injection from 2021 to 2026.
Chapter 3, the Ferric Carboxymaltose Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ferric Carboxymaltose Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ferric Carboxymaltose Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ferric Carboxymaltose Injection.
Chapter 14 and 15, to describe Ferric Carboxymaltose Injection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Ferric Carboxymaltose Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 2 ml
- 1.3.3 10 ml
- 1.3.4 20 ml
- 1.3.5 15 ml
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Ferric Carboxymaltose Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Global Ferric Carboxymaltose Injection Market Size & Forecast
- 1.5.1 Global Ferric Carboxymaltose Injection Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Ferric Carboxymaltose Injection Sales Quantity (2021-2032)
- 1.5.3 Global Ferric Carboxymaltose Injection Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Daiichi Sankyo
- 2.1.1 Daiichi Sankyo Details
- 2.1.2 Daiichi Sankyo Major Business
- 2.1.3 Daiichi Sankyo Ferric Carboxymaltose Injection Product and Services
- 2.1.4 Daiichi Sankyo Ferric Carboxymaltose Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Daiichi Sankyo Recent Developments/Updates
- 2.2 Vifor Pharma
- 2.2.1 Vifor Pharma Details
- 2.2.2 Vifor Pharma Major Business
- 2.2.3 Vifor Pharma Ferric Carboxymaltose Injection Product and Services
- 2.2.4 Vifor Pharma Ferric Carboxymaltose Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Vifor Pharma Recent Developments/Updates
- 2.3 Hencer Pharma
- 2.3.1 Hencer Pharma Details
- 2.3.2 Hencer Pharma Major Business
- 2.3.3 Hencer Pharma Ferric Carboxymaltose Injection Product and Services
- 2.3.4 Hencer Pharma Ferric Carboxymaltose Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Hencer Pharma Recent Developments/Updates
- 2.4 Lupin
- 2.4.1 Lupin Details
- 2.4.2 Lupin Major Business
- 2.4.3 Lupin Ferric Carboxymaltose Injection Product and Services
- 2.4.4 Lupin Ferric Carboxymaltose Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Lupin Recent Developments/Updates
- 2.5 Weefsel Pharma
- 2.5.1 Weefsel Pharma Details
- 2.5.2 Weefsel Pharma Major Business
- 2.5.3 Weefsel Pharma Ferric Carboxymaltose Injection Product and Services
- 2.5.4 Weefsel Pharma Ferric Carboxymaltose Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Weefsel Pharma Recent Developments/Updates
- 2.6 Apollo Pharmacy
- 2.6.1 Apollo Pharmacy Details
- 2.6.2 Apollo Pharmacy Major Business
- 2.6.3 Apollo Pharmacy Ferric Carboxymaltose Injection Product and Services
- 2.6.4 Apollo Pharmacy Ferric Carboxymaltose Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Apollo Pharmacy Recent Developments/Updates
- 2.7 Cipla
- 2.7.1 Cipla Details
- 2.7.2 Cipla Major Business
- 2.7.3 Cipla Ferric Carboxymaltose Injection Product and Services
- 2.7.4 Cipla Ferric Carboxymaltose Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Cipla Recent Developments/Updates
- 2.8 Bosch Pharmaceuticals
- 2.8.1 Bosch Pharmaceuticals Details
- 2.8.2 Bosch Pharmaceuticals Major Business
- 2.8.3 Bosch Pharmaceuticals Ferric Carboxymaltose Injection Product and Services
- 2.8.4 Bosch Pharmaceuticals Ferric Carboxymaltose Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Bosch Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Ferric Carboxymaltose Injection by Manufacturer
- 3.1 Global Ferric Carboxymaltose Injection Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Ferric Carboxymaltose Injection Revenue by Manufacturer (2021-2026)
- 3.3 Global Ferric Carboxymaltose Injection Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Ferric Carboxymaltose Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Ferric Carboxymaltose Injection Manufacturer Market Share in 2025
- 3.4.3 Top 6 Ferric Carboxymaltose Injection Manufacturer Market Share in 2025
- 3.5 Ferric Carboxymaltose Injection Market: Overall Company Footprint Analysis
- 3.5.1 Ferric Carboxymaltose Injection Market: Region Footprint
- 3.5.2 Ferric Carboxymaltose Injection Market: Company Product Type Footprint
- 3.5.3 Ferric Carboxymaltose Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Ferric Carboxymaltose Injection Market Size by Region
- 4.1.1 Global Ferric Carboxymaltose Injection Sales Quantity by Region (2021-2032)
- 4.1.2 Global Ferric Carboxymaltose Injection Consumption Value by Region (2021-2032)
- 4.1.3 Global Ferric Carboxymaltose Injection Average Price by Region (2021-2032)
- 4.2 North America Ferric Carboxymaltose Injection Consumption Value (2021-2032)
- 4.3 Europe Ferric Carboxymaltose Injection Consumption Value (2021-2032)
- 4.4 Asia-Pacific Ferric Carboxymaltose Injection Consumption Value (2021-2032)
- 4.5 South America Ferric Carboxymaltose Injection Consumption Value (2021-2032)
- 4.6 Middle East & Africa Ferric Carboxymaltose Injection Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Ferric Carboxymaltose Injection Sales Quantity by Type (2021-2032)
- 5.2 Global Ferric Carboxymaltose Injection Consumption Value by Type (2021-2032)
- 5.3 Global Ferric Carboxymaltose Injection Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Ferric Carboxymaltose Injection Sales Quantity by Application (2021-2032)
- 6.2 Global Ferric Carboxymaltose Injection Consumption Value by Application (2021-2032)
- 6.3 Global Ferric Carboxymaltose Injection Average Price by Application (2021-2032)
7 North America
- 7.1 North America Ferric Carboxymaltose Injection Sales Quantity by Type (2021-2032)
- 7.2 North America Ferric Carboxymaltose Injection Sales Quantity by Application (2021-2032)
- 7.3 North America Ferric Carboxymaltose Injection Market Size by Country
- 7.3.1 North America Ferric Carboxymaltose Injection Sales Quantity by Country (2021-2032)
- 7.3.2 North America Ferric Carboxymaltose Injection Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Ferric Carboxymaltose Injection Sales Quantity by Type (2021-2032)
- 8.2 Europe Ferric Carboxymaltose Injection Sales Quantity by Application (2021-2032)
- 8.3 Europe Ferric Carboxymaltose Injection Market Size by Country
- 8.3.1 Europe Ferric Carboxymaltose Injection Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Ferric Carboxymaltose Injection Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Ferric Carboxymaltose Injection Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Ferric Carboxymaltose Injection Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Ferric Carboxymaltose Injection Market Size by Region
- 9.3.1 Asia-Pacific Ferric Carboxymaltose Injection Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Ferric Carboxymaltose Injection Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Ferric Carboxymaltose Injection Sales Quantity by Type (2021-2032)
- 10.2 South America Ferric Carboxymaltose Injection Sales Quantity by Application (2021-2032)
- 10.3 South America Ferric Carboxymaltose Injection Market Size by Country
- 10.3.1 South America Ferric Carboxymaltose Injection Sales Quantity by Country (2021-2032)
- 10.3.2 South America Ferric Carboxymaltose Injection Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Ferric Carboxymaltose Injection Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Ferric Carboxymaltose Injection Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Ferric Carboxymaltose Injection Market Size by Country
- 11.3.1 Middle East & Africa Ferric Carboxymaltose Injection Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Ferric Carboxymaltose Injection Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Ferric Carboxymaltose Injection Market Drivers
- 12.2 Ferric Carboxymaltose Injection Market Restraints
- 12.3 Ferric Carboxymaltose Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Ferric Carboxymaltose Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Ferric Carboxymaltose Injection
- 13.3 Ferric Carboxymaltose Injection Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Ferric Carboxymaltose Injection Typical Distributors
- 14.3 Ferric Carboxymaltose Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Ferric Carboxymaltose Injection. Industry analysis & Market Report on Ferric Carboxymaltose Injection is a syndicated market report, published as Global Ferric Carboxymaltose Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Ferric Carboxymaltose Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
